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SUMMARY
Although many transcription factors are known to control important aspects of neural development,
the genome-wide programs that are directly regulated by these factors are not known. We have
characterized the genetic program that is activated by MEF2, a key regulator of activity-dependent
synapse development. These MEF2 target genes have diverse functions at synapses, revealing a broad
role for MEF2 in synapse development. Several of the MEF2 targets are mutated in human
neurological disorders including epilepsy and autism-spectrum disorders, suggesting that these
disorders may be caused by disruption of an activity-dependent gene program that controls synapse
development. Our analyses also reveal that neuronal activity promotes alternative polyadenylation
site usage at many of the MEF2 target genes, leading to the production of truncated mRNAs that
may have different functions than their full-length counterparts. Taken together, these analyses
suggest that the ubiquitously expressed transcription factor MEF2 regulates an intricate
transcriptional program in neurons that controls synapse development.
INTRODUCTION
In the central nervous system (CNS), environmental stimuli regulate the development and
function of neural circuits that underlie behavior and cognition. Sensory experience, which
leads to an increase in neurotransmitter release onto individual neurons in the CNS, promotes
both the maturation of synapses and the elimination of excess synapses within various neural
circuits during postnatal development (Hua and Smith, 2004), and drives experience-dependent
changes in synaptic connectivity that underlie learning and memory (Malinow and Malenka,
2002). One way increased neurotransmitter release triggers changes in circuit connectivity is
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through new gene transcription. Increased synaptic activity leads to calcium influx into the
postsynaptic cell, which activates calcium-dependent signaling pathways that in turn regulate
transcription factors within the nucleus (Flavell and Greenberg, 2008). Several transcription
factors that mediate neuronal activity-dependent transcription in neurons, including CREST
and NeuroD, control early steps of neural circuit development such as dendritic outgrowth
(Aizawa et al., 2004; Gaudilliere et al., 2004). Other activity-regulated transcription factors,
including CREB, SRF, NeuroD2, and MEF2 family members, regulate later aspects of circuit
development by controlling synaptic development and function (Barco et al., 2002; Etkin et
al., 2006; Flavell et al., 2006; Ince-Dunn et al., 2006; Ramanan et al., 2005; Shalizi et al.,
2006).
Despite evidence that individual activity-regulated transcription factors control specific aspects
of neural circuit development, the molecular mechanisms by which these factors coordinate
complex processes such as dendritic outgrowth and synaptic development remain unclear.
Previous studies have for the most part identified the target genes of activity-dependent
transcription factors one at a time. Thus, the diversity and complexity of the activity-regulated
gene networks remain to be investigated. For example, except perhaps for CREB which has
been suggested to control hundreds of target genes in neuronal cell lines (Impey et al., 2004),
it is not known if a given activity-regulated transcription factor regulates the expression of
several or perhaps hundreds of target genes in order to coordinate a specific aspect of neural
circuit development.
MEF2 family transcription factors are critical for the development and function of many types
of cells, including those found in the musculoskeletal, cardiac, vascular, immune and nervous
systems (Potthoff and Olson, 2007). In all of these contexts, MEF2 transcriptional activity is
tightly regulated by extracellular stimuli. In neurons, MEF2 can be activated by neurotrophin
stimulation as well as calcium influx resulting from increased neurotransmitter release at
synapses. The neuronal activity-dependent activation of MEF2 induces a program of gene
expression that restricts the number of excitatory synapses formed onto hippocampal neurons,
cerebellar granule neurons and medium spiny neurons of the nucleus accumbens both in
vitro and in vivo (Barbosa et al., 2008; Flavell et al., 2006; Pulipparacharuvil et al., 2008;
Shalizi et al., 2006). Furthermore, the disruption of MEF2 expression in vivo in the
hippocampus or the nucleus accumbens results in deficits in behavioral plasticity that are
correlated with an increase in excitatory synapse number (Barbosa et al., 2008;
Pulipparacharuvil et al., 2008). Consistent with a widespread role for MEF2 in synapse
development, a similar function for MEF2 has also been identified in species as distant from
mammals as the nematode C. elegans, where mef-2 negatively regulates excitatory synaptic
function at the cholinergic neuromuscular synapse (Simon et al., 2008). Despite the importance
of MEF2 as a mediator of activity-dependent synaptic development in a wide range of species,
the mechanisms by which MEF2 orchestrates synaptic maturation are not known.
To examine how MEF2 coordinates synapse development in response to neuronal activity, we
have applied genome-wide strategies to identify the full complement of target genes that are
controlled by MEF2 in neurons during the process of activity-dependent synapse development.
This approach of understanding the function of a transcription factor through the identification
of its target genes has the potential to reveal mechanistic insights into transcription factor
function that might be missed by traditional loss-of-function experiments (through RNAi or
gene targeting). Using the loss-of function approach, it is often difficult to discern the direct
effects of transcription factor removal (resulting from altered expression of its direct target
genes) from the homeostatic effects that arise as an indirect consequence of altering the
expression of an entire transcriptional program for several days.
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In this study, we have used genome-wide approaches to identify 182 activity-dependent MEF2
target genes that regulate a variety of different aspects of synaptic function including excitatory
synapse weakening, excitatory synapse maturation, inhibitory synapse development and
presynaptic vesicle release. Mutations in several of the MEF2 target genes in the human
population result in an increased susceptibility to neurological disorders such as epilepsy and
autism-spectrum disorders, suggesting that these disorders may be caused at least in part by
disruption of activity-dependent gene networks that control synapse development. One striking
feature of the gene network controlled by MEF2 is that in response to neuronal activity there
is a switch in polyadenylation site usage at many MEF2 target genes that results in the activity-
dependent production of truncated mRNAs, many of which are predicted to have functions
that are distinct from their pre-existing, full-length counterparts. Taken together, these
experiments reveal new mechanisms by which the activity-regulated transcription factor MEF2
coordinates synaptic maturation during brain development.
RESULTS AND DISCUSSION
mRNA expression profiling reveals activity-regulated MEF2 target genes in hippocampal
neurons
As a first step towards defining the activity-regulated MEF2-dependent transcriptional
program that controls synapse development, we conducted an mRNA profiling experiment to
identify activity-regulated genes in hippocampal neurons undergoing synapse development.
Hippocampal neurons harvested from embryonic day 18 (E18) rats were grown in dissociated
cultures for 10 days in vitro (DIV). Hippocampal neurons at this stage in their development
are undergoing extensive changes in both synapse number and synaptic strength, and we have
previously shown that the manipulation of MEF2 activity in these cells alters the course of
synapse development (Flavell et al., 2006). To identify activity-regulated genes that might
control synapse development, we exposed neurons to elevated levels of extracellular potassium
chloride (KCl), which leads to membrane depolarization and calcium influx via L-type voltage-
gated calcium channels. Using Affymetrix RAE230.2 microarrays that include ~30,000 probe
sets, we identified 643 probe sets that are upregulated after one or six hours of membrane
depolarization (Fig. 1A). Importantly, a large number of the genes we identified are also
activated by physiological levels of neurotransmitter release in vivo, including c-fos, bdnf,
gadd45b, nur77, egr1, arc and many others (Majdan and Shatz, 2006).
To determine which of these activity-regulated genes might be targets of MEF2 that control
synapse development, MEF2 expression in neurons was reduced by introducing into the
neurons MEF2A- and MEF2D-specific shRNAs using lentiviral vectors. By comparing the
microarray results between the control (scrambled shRNA expression) and MEF2 RNAi
conditions both before and after membrane depolarization, we were able to identify a large set
of genes whose expression is altered as a result of MEF2 knockdown (1365 probe sets
identified; Fig. 1B).
When the genes whose expression is downregulated in the presence of MEF2 RNAi (at any
time point) are pooled together into a single gene set, there is a highly significant level of
overlap between this gene set and the activity-regulated gene set (151 overlapping probe sets,
p<0.0001, Fisher Exact Test; Fig. 1D). The genes that are present in both gene sets are most
often decreased in their expression in the presence of MEF2 RNAi either one or six hours after
membrane depolarization (147/151, or 97%), but only rarely in unstimulated cells (25/151, or
17%). Importantly, the majority (70%) of the activity-regulated genes identified in our initial
analysis are induced normally even in the presence of MEF2 RNAi. This indicates that the
knockdown of MEF2 does not prevent activity-dependent gene expression generally, but
instead alters the expression of a subset of activity-regulated genes.
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It is possible that in the MEF2 loss-of-function experiments we might have failed to identify
particular activity-regulated MEF2 target genes because another transcription factor
compensates for the loss of MEF2 at the promoters of these genes. To circumvent this potential
problem, we performed a MEF2 gain-of-function experiment in hippocampal neurons at the
time that synapses are forming and maturing. For these experiments we employed an inducible
form of MEF2 in which the ligand binding domain of the estrogen receptor (ER) is fused to
the C-terminus of the constitutively active MEF2-VP16 fusion protein to generate MEF2-
VP16-ER. We have previously shown that in the absence of the ER ligand 4-OH-Tamoxifen
(4OHT), MEF2-VP16-ER remains sequestered in the cytoplasm of hippocampal neurons and
is inactive (Flavell et al., 2006). However, upon addition of 4OHT to the culture media MEF2-
VP16-ER rapidly translocates to the nucleus and activates MEF2-dependent transcription.
Hippocampal neurons were transduced with a lentivirus that drives the expression of MEF2-
VP16-ER and mRNA profiling experiments were performed in the absence or presence of
4OHT using the same microarray platform described above. To control for the non-specific
effects that 4OHT application or MEF2-VP16-ER expression might have on gene expression,
we generated a lentivirus that expresses a DNA binding-deficient control version of MEF2-
VP16-ER (MEF2ΔDBD-VP16-ER) and performed a parallel series of experiments using
neurons transduced with this virus. Probe sets that were upregulated in response to 4OHT
application in both MEF2-VP16-ER- and MEF2ΔDBD-VP16-ER-expressing neurons were
excluded from further analysis.
We identified 251 probe sets that display increased expression in neurons expressing MEF2-
VP16-ER within one or 2.5 hours of 4OHT application, but not in neurons expressing
MEF2ΔDBD-VP16-ER (Fig. 1C). We asked whether these probe sets overlap with the activity-
regulated gene set or the set of genes whose expression is downregulated in the presence of
MEF2 RNAi. In both cases there was a highly significant degree of overlap (75 and 55 probe
sets, respectively, p<0.0001 for both comparisons, Fisher Exact Test; Fig. 1D), whereas the
group of probe sets that were downregulated as a consequence of 4OHT application to MEF2-
VP16-ER-expressing neurons did not significantly overlap with either of the other gene sets.
Moreover, the MEF2-VP16-ER-induced gene set did not overlap with genes whose expression
is increased in the presence of MEF2 RNAi or genes whose expression decreased upon KCl
treatment. These data demonstrate that the gain-of-function approach to MEF2 target gene
identification largely corroborates the loss-of-function approach.
Because the genes identified by the KCl depolarization, MEF2 RNAi and MEF2-VP16-ER
experiments overlap in a manner that is statistically significant and converge on a common set
of genes (Fig. 1D), it is likely that the genes that are present in more than one of these gene
sets include the bona fide activity-regulated MEF2 target genes in hippocampal neurons. In
our subsequent studies we only considered genes identified in at least two of these three gene
sets. This approach allows for the possibilities that any single one of the approaches to MEF2
target gene discovery might not have detected all of the activity-regulated MEF2 target genes
and that some of the genes present in one particular gene set might not be bona fide activity-
regulated MEF2 target genes. We found that 221 probe sets were present in at least two of
these three gene sets (Table S1). These probe sets map to 182 non-redundant genes that can be
confidently mapped in the rat genome and were therefore the subject of further analysis. We
randomly selected 15 of these genes for validation by an independent method, reverse
transcription-quantitative PCR (RT-qPCR), and found that over 95% of the expression changes
that were initially identified by the microarray analysis were confirmed by RT-qPCR (Fig. S1–
S3). These data indicate that the results from these microarray experiments have a low false
discovery rate.
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In vivo validation of mRNA profiling results
Because these initial experiments were performed using cultured neurons, we examined
whether the set of candidate MEF2 target genes identified in these experiments are also induced
upon physiological stimulation of neurons in the intact brain. To address this issue, we
conducted a microarray analysis to identify genes whose expression is increased in response
to sensory experience. To enhance levels of sensory experience, rats that had been housed in
a standard laboratory cage (control) were placed for three hours in a novel cage containing
objects of different shapes and colors that induce exploratory behavior, a procedure that has
previously been shown to lead to new gene transcription in neurons in the forebrain (novel
environment; (Nithianantharajah and Hannan, 2006; Ramanan et al., 2005)). We identified 304
probe sets that display increased expression in the forebrains of rats exposed to a novel
environment (n = 6 animals per condition; Fig. 1E). These microarray results were also
validated by RT-qPCR (Fig. S4). The candidate MEF2 target genes characterized in cultured
hippocampal neurons represent a large fraction (16%, or 48/304) of the genes that are
upregulated in vivo in response to new sensory experience. Moreover, 22% (48/221) of the
candidate MEF2 target genes that are upregulated as a result of membrane depolarization of
cultured neurons are also induced by new sensory experiences in vivo, a level that is far greater
than would be expected by chance alone (p<0.0001, Fisher Exact test). Consistent with these
results, a large number of the candidate MEF2 target genes were also identified in a screen for
genes whose expression is increased in neurons in primary visual cortex in response to visual
stimulation (including c-fos, bdnf, gadd45b, nur77, egr1, arc and many others; (Majdan and
Shatz, 2006)).
For individual genes, the fold increase in gene expression in response to KCl treatment in
vitro was highly correlated with the fold increase in gene expression in response to exposure
to a novel environment (R2=0.36; p<0.0001), although the level of induction was consistently
less robust in the novel environment experiment. This suggests that these two types of
stimulation activate gene expression through similar mechanisms. However, the in vivo
experiment appears to be less sensitive at detecting activity-regulated changes in gene
expression, likely due to the heterogeneity of the cell population. Nevertheless, because the
gene expression changes detected by these two approaches are highly correlated and overlap
significantly, we conclude that a large fraction of the candidate MEF2 target genes identified
in cultured neurons are induced in the brains of mice exposed to novel sensory experiences.
ChIP-chip to identify MEF2 binding sites in the genome: direct MEF2 target genes
The mRNA profiling experiments described above do not address whether the genes identified
are direct or indirect targets of MEF2. To determine which of these genes are directly regulated
by MEF2 and to provide additional confirmation that our microarray experiments had indeed
identified MEF2 target genes, we performed chromatin immunoprecipitation followed by tiling
microarray analysis (ChIP-chip) to identify MEF2D binding sites within the regulatory regions
of these 182 genes. We developed ChIP conditions under which a MEF2D-specific antibody
immunoprecipitated DNA fragments of the nur77 proximal promoter, a genomic region known
to be bound by MEF2 (Fig. S5; (Youn et al., 2000)). Preabsorption of the anti-MEF2D antibody
with the peptide antigen used to generate the antibody blocked its ability to immunoprecipitate
MEF2D proteins as well as nur77 promoter DNA fragments (Fig. S5). Because these
polyclonal anti-MEF2D antibodies might non-specifically immunoprecipitate some DNA
fragments and therefore lead to the mis-identification of MEF2D binding sites, we used the
MEF2 peptide-absorbed anti-MEF2D antibody as a negative control in all of the MEF2D ChIP-
chip experiments described below.
We performed MEF2D ChIP-chip using a custom tiling microarray containing the genomic
loci of the 182 genes identified in our mRNA profiling experiments (including 10 kb 5′ and 3′
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to the genes). In these experiments, we also mapped the transcriptional start sites (TSSs) within
the putative MEF2 target genes by performing ChIP-chip with an antibody that specifically
recognizes RNA polymerase II when bound to sites of transcription initiation (Fig. 2C–D;
(Mikkelsen et al., 2007)). To identify regions of MEF2D and RNA polymerase II occupancy,
we developed a “peak-calling” algorithm that identified reproducible regions of MEF2D or
RNA polymerase II binding that were not detected in negative control ChIP experiments
conducted in parallel. Binding of MEF2D to a subset of the genomic regions identified through
ChIP-chip was verified by subsequent ChIP-qPCR experiments (92%, or 12 of the 13 regions
tested; Fig. S6). These data indicate that the ChIP-chip approach can be used to identify regions
of MEF2D occupancy in the rat genome.
Of the 182 genes examined, 78 (43%) have MEF2D binding sites within the gene (including
gene exons and introns) or within 10 kB 5′ or 3′ of the gene (Table S2). This represents a notable
increase over the background level of MEF2 binding detected on a separate chromosomal tiling
microarray that was carried out as a control (8.8%) and MEF2 binding to arbitrarily selected
control genes that were included on our custom tiling microarray (21%). These experiments
demonstrate that the genes identified in our expression analyses display an enrichment of
nearby regions of MEF2D occupancy and indicate that a large number of the genes identified
by the gene expression analyses are likely to be direct targets of MEF2.
Bioinformatic analyses of the genomic regions of MEF2D occupancy
To determine whether the genomic regions of MEF2D occupancy that we identified serve as
functionally important MEF2 binding sites, we performed several analyses. First, we reasoned
that if these genomic regions play critical roles in gene regulation, the nucleotide sequences
within these regions should be highly conserved through vertebrate evolution. Indeed,
compared to other sequences included on the tiling microarray, the MEF2D-bound regions are
signficantly enriched for evolutionarily conserved nucleotides (p<0.001, Chi-Square test; Fig.
2E). Second, we asked whether a specific nucleotide sequence motif was more commonly
found within the MEF2D-bound genomic regions than elsewhere in the rat genome. An
unbiased analysis of these genomic regions identified a 10-nucleotide motif that is significantly
enriched within these regions and can be found in 80% of the regions of MEF2D occupancy.
This sequence ((C/T)TA(T)4TA(G/A)) is nearly identical to the previously characterized
MEF2 binding site, (C/T)TA(T/A)4TA(G/A), also termed the MEF2 response element (MRE;
Fig. 2F; (Potthoff and Olson, 2007)). Compared to identical sequences found elsewhere in the
rat genome (this sequence is predicted to occur randomly every ~350 base pairs), the MREs
found within regions of MEF2D binding are significantly more likely to be conserved through
vertebrate evolution (p<0.01, Chi-Square test; Fig. 2G), suggesting that they are likely to be
functionally important. Taken together with the mRNA profiling experiments, these analyses
strongly suggest that MEF2, by binding to evolutionarily conserved MREs near MEF2 target
genes, directly regulates the expression of a large set of activity-regulated genes in neurons at
the time that synapses are developing and maturing.
The sites of MEF2D binding were often (28% of the sites) located close to the 5′ ends of
Reference Sequence (RefSeq)-annotated mRNAs transcribed from the MEF2-regulated genes,
suggesting that these MEF2D binding sites form part of the proximal promoters of these genes
(within 2.5 kb; Fig. 3A–B). In addition to these binding sites, we also identified several MEF2D
binding sites (8% of the sites) that were located near TSSs identified by RNA polymerase II
ChIP-chip but were not close to the 5′ ends of any RefSeq-annotated mRNAs (Fig. 3C). It is
likely that these MEF2D binding sites also form part of the proximal promoters of these genes,
but that the mRNAs produced by these genes have not yet been fully annotated.
The remaining 64% of the MEF2 binding sites that we identified using ChIP-chip occurred in
regions of genes where there was no evidence to suggest that transcription is initiated nearby
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(within 2.5 kb; Fig. 3D). We found that the magnitude of the changes in mRNA expression
observed in the gene expression analyses (Fig. 1) did not correlate with the distance of the
MEF2D binding site from the TSS of the gene, suggesting that both proximally and distally
located MEF2D binding sites are important for activity-dependent gene regulation. Consistent
with this conclusion, luciferase reporter experiments examining the function of a MEF2
binding site located far upstream (~6.5 kb) of bdnf promoter I indicate that this MEF2 binding
site is critical for activity-dependent bdnf promoter I transcription (Fig. 3D–E). We conclude
from these data that MEF2 can regulate activity-dependent transcription by binding to
evolutionarily conserved MREs in proximal promoters as well as distal enhancers at numerous
MEF2 target genes.
Activity-dependent changes in polyadenylation site usage
One striking and unexpected feature of the activity-regulated MEF2 genetic program was
revealed by an investigation of alternative exon usage within this transcriptional program
before and after membrane depolarization of cultured neurons. Using the microarray data that
were collected from hippocampal neurons before and after membrane depolarization, we
performed a search for genes that have one or more exon that displays increased expression
upon membrane depolarization while other exon(s) do not (referred to as activity-dependent
exon usage). We identified ~70 genes that fulfill this criterion, including many of the newly
identified MEF2 target genes. We were able to validate numerous cases of activity-dependent
exon usage by performing RT-qPCR with primers that correspond to the distinct exons within
these genes (Fig. 4A). Using this approach, we also verified that the activity-dependent changes
in exon usage observed at several of these genes occur in neurons in primary visual cortex in
response to light stimulation (Fig. 4B). Taken together, these data indicate that the microarray
results reveal a genuine activity-dependent switch in exon usage that occurs in vitro and in
vivo at numerous genes, including many MEF2 target genes.
Activity-dependent changes in exon usage could be due to activity-dependent changes in the
sites of transcriptional initiation, changes in splicing, or alterations in transcriptional
termination and polyA tail addition. Further analysis of the genes that display an activity-
dependent switch in exon usage revealed that the activity-regulated exons within these genes
are most commonly found 5′ to non-activity-regulated exons within the same genes (78% of
the time; Fig. 4C). We also found that the mRNAs that are produced from these genes in
response to membrane depolarization have polyA tails immediately 3′ to the sequences that
correspond to the activity-regulated exons within these mRNAs (Fig. 4A). In addition,
hexamers corresponding to the known signal for polyA tail addition (AATAAA and closely
related sequences; (Tian et al., 2005)) could be found in their characteristic position 5 to 35
base pairs 5′ to the sites of polyA tail addition in these mRNAs (Fig. 4D–E). These results
indicate that the activity-regulated exons within the mRNAs that are expressed in response to
membrane depolarization are the terminal (3′-most) exons within these mRNAs. Thus, prior
to stimulation, the mRNAs produced from these genes are typically expressed at lower levels
and are longer (including additional exon(s) or a longer 3′ UTR) than the mRNAs that are
produced upon membrane depolarization. Taken together, these findings suggest that for a
group of activity-regulated genes, including many MEF2 target genes, there is a switch in
polyA site usage that favors the production of shorter mRNAs that utilize internal sites of polyA
tail addition.
Several additional lines of evidence support this conclusion. First, using an RT-PCR-based
approach, we verified that the distinct mRNA isoforms produced by these genes while they
differ in their 3′ ends share the same 5′ exons (Fig. 4F). This demonstrates that the shortened
mRNAs that are present after stimulation belong to the same transcriptional units as the full-
length mRNAs that are present prior to membrane depolarization. We also investigated RNA
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polymerase II pausing at the activity-regulated genes that display activity-dependent polyA
site switching. Recent studies have revealed that the RNA polymerase II complex pauses after
polyA hexamers at the 3′ ends of genes, leading to transcription termination, mRNA cleavage
and polyA tail addition (Gromak et al., 2006). Consistent with these results, we detect an
enrichment of RNA polymerase II at the 3′ end of neuron-specific gene beta-3-tubulin and an
activity-dependent increase in RNA polymerase II occupancy at the 3′ end of the activity-
regulated gene rgs2 (Fig. 5A). However, at homer1 and other activity-regulated genes that our
analyses indicate display polyA site switching, activity-dependent RNA polymerase II pausing
was detected at the 3′ end of the short mRNA rather than the 3′ end of the full-length mRNA
(Fig. 5A). This indicates that increased neuronal activity leads to RNA polymerase II pausing
in genomic regions surrounding the sites of activity-dependent polyA tail addition, which likely
leads to the cleavage of pre-mRNAs in this region, followed by the addition of a polyA tail.
Taken together with the analyses described above, these data provide strong evidence that
neuronal activity leads to polyA site switching at a number of activity-regulated genes,
including many MEF2 target genes.
Molecular mechanisms underlying activity-dependent polyA site switching
We took several approaches to begin to identify the molecular mechanisms by which neuronal
activity triggers polyA site switching. Although our bioinformatic analyses indicated that the
genomic regions surrounding the sites of activity-regulated polyA tail addition have features
of typical sites of polyA tail addition (including the polyA signal hexamer, AATAAA and
closely related sequences; Fig. 4D–E), we performed an unbiased search for additional
nucleotide sequence motifs that were specifically enriched within the genomic regions where
activity-dependent mRNA cleavage and polyA tail addition occur. This analysis resulted in
the identification of a novel motif that was present in many of these genomic regions (42%;
TTGTTGGG; Fig. 5B), but was only rarely found in the genomic regions that surround non-
activity-regulated sites of polyA tail addition (8%). While the function of this motif is not yet
clear, our bioinformatic analyses suggest that this sequence motif may play an important role
in directing activity-dependent polyadenylation to specific sites, perhaps by promoting
activity-dependent pausing of RNA polymerase II in these specific genomic regions, leading
to mRNA cleavage and polyA tail addition.
To determine how neuronal activity might trigger RNA polymerase II pausing and polyA tail
addition at these genes, we monitored the expression of both the short and full-length mRNAs
produced by several of the genes that display activity-dependent polyA site switching
(including several MEF2 target genes) and performed a pharmacological screen to identify
agents that altered the activity-dependent expression of these mRNAs. None of the
pharmacological agents applied (15 total) successfully dissociated the process of activity/
MEF2-dependent transcription from the process of activity/MEF2-dependent polyA tail
addition at any of the genes examined (Fig. 5C and data not shown). This result suggests that
these two processes might be coupled. However, we note that MEF2 is not the only transcription
factor that can couple activity-dependent transcription to activity-dependent polyA site
switching, as 41 activity-regulated genes that are not regulated by MEF2 also display a switch
in polyA site usage in response to membrane depolarization. Although we were unable to
dissociate the processes of activity-dependent transcriptional intiation and polyA site
switching, we were able to identify several agents (the calcium chelator EGTA, the L-type
voltage-gated calcium channel (L-VGCC) antagonist nimodipine, and the cAMP-regulated
protein kinase (PKA) inhibitor H89) that prevented the activity-dependent transcription/
polyadenylation of each of the short mRNAs that were examined. These data indicate that the
activity-dependent induction of truncated mRNAs is due to the coupling of activity-dependent
transcription and activity-dependent polyA site switching at select genes, and requires calcium
influx through L-VGCCs, as well as the activation of PKA (Fig. 5C).
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PolyA site switching in other transcriptional programs
In considering the potential functions of activity-dependent polyA site switching, we reasoned
that this mechanism might exist to promote the expression of short mRNA transcripts that are
important for activity- and MEF2-dependent synapse development. Consistent with this idea,
when we monitored the expression of several of these short mRNAs, we found that application
of other extracellular factors that do not promote activity- and MEF2-dependent synapse
development in hippocampal neurons (such as BDNF, NT-4, EGF and forskolin) does not lead
to polyA site switching at the same set of genes that display this switch in response to increased
neuronal activity (data not shown).
Nevertheless, we reasoned that extracellular stimulus-dependent polyA site switching might
be a general mechanism used by cells in a variety of different contexts to alter gene function
in response to changes in their environment. To determine whether application of other
extracellular factors to cells leads to polyA site switching at genes that do not display this
switch in response to neuronal activity, we analyzed a number of publicly available microarray
data sets. We were able to identify genes that displayed polyA site switching in response to:
(1) EGF application to astrocytes, (2) interleukin-2 application to T cells and (3) anti-IgM and
CpG co-application to B cells. Furthermore, while this paper was under review, a separate
study showed that stimulation of several types of immune cells also causes polyA site
switching, which leads to the production of shortened mRNAs (Sandberg et al., 2008). The
sets of genes that display polyA site switching in these different cellular contexts are almost
completely non-overlapping (Fig. 5D). These data indicate that a wide variety of extracellular
factors can trigger polyA site switching, but the specific genes that display this switch vary
depending on the cell type and the extracellular stimulus.
Functional consequences of activity-dependent polyA site switching
Activity-dependent polyA site switching is likely to play a widespread role in the regulation
of neuronal gene expression (see Table 1 for full list of genes that display this switch). This
gene regulatory mechanism significantly alters the functions of ~10% of the mRNAs that are
transcribed from MEF2 target genes in response to increased neuronal activity. The shortened,
activity-regulated mRNAs are often predicted to encode proteins that are functionally distinct
from the proteins encoded by the full-length mRNAs produced by the same gene. For instance,
these mRNAs are predicted to encode scaffolding proteins that lack one or more of their C-
terminal protein-protein interaction domains (homer1, jip3), signaling enzymes that lack C-
terminal regulatory domains (casein kinase I epsilon, arhgef9) and transport proteins that lack
their ability to transport dendritic mRNAs (kif5c; (Kanai et al., 2004)). In the case of
homer1, the shortened mRNA encodes a dominant-negative form of homer1 that disrupts full-
length homer1 function and restricts excitatory synapse number (Sala et al., 2003).
For other genes, the only difference between the shortened, activity-regulated mRNAs and the
full-length mRNAs is that the shortened mRNAs lack a portion of their 3′UTRs. Interestingly,
a recent study showed that the truncation of 3′ UTRs as a result of polyA site switching removes
microRNA binding sites that repress mRNA translation (Sandberg et al., 2008). Thus, while
these mRNAs are predicted to encode the same proteins as the full-length mRNAs, they likely
lack elements within their 3′ UTRs that might specify where and when the mRNAs will be
translated.
Based on the homer1 example, as well as our analyses of the sequences of the other newly
identified truncated mRNAs, we hypothesize that stimulus-dependent polyA site switching
might be a general mechanism used to alter gene function in response to changes in a cell’s
extracellular environment. It is possible that stimulus-regulated transcriptional programs such
as the activity-dependent MEF2 genetic program commonly use polyA site switch mechanisms
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to interfere with or alter the function of pre-existing proteins. Because new gene transcription
does not necessarily lead to the disappearance of stably expressed proteins, the production of
shortened, dominantly interfering or activating forms of these proteins may provide an efficient
way to acutely disrupt or alter the function of existing proteins. Given that the remodeling of
synapses likely requires the destabilization of existing structures (through activity-regulated
genes like homer1a), the polyA site switch mechanism may have evolved to generate truncated
proteins and/or mRNAs that can acutely reverse cellular processes such as synapse
development.
MEF2 target genes that function at synapses to control synaptic remodeling
A striking feature of the group of MEF2 target genes that we have identified is that this set of
genes displays enriched expression specifically within the CNS (based on comparisons to GNF
Atlas 2 expression data; (Su et al., 2004); Table S3) and a large number of these genes encode
proteins that function at neuronal synapses (p=2.14 ×10−7, enrichment for Synaptic
Transmission GO category, Ingenuity Pathway Analysis; Fig. 6). In support of the recently
described function of MEF2 in restricting the number of excitatory synapses that form on
neurons, many of the MEF2 targets we have identified are known to contribute to the
weakening/loss of excitatory synapses by regulating different aspects of signal transduction
on the postsynaptic side of the synapse: Homer1a is involved in the disassembly of postsynaptic
scaffolding complexes (Sala et al., 2003), while Activity-regulated cytoskeletal protein (Arc)
and c-jun N-terminal kinase (Jnk) promote AMPAR removal from the postsynaptic membrane
(Chowdhury et al., 2006; Zhu et al., 2005). The MEF2 target genes also include three members
of the delta subfamily of protocadherins (protocadherins 9, 10, and 17), which have recently
been shown to restrict the number of synapses formed onto neurons by promoting the
internalization of N-cadherin, a synaptic adhesion molecule that stabilizes excitatory synapses
(Yasuda et al., 2007). Finally, increased expression of the postsynaptically localized potassium
channels encoded by the MEF2 target genes kcna1 and kcna4 would also be predicted to
decrease excitatory postsynaptic strength, as dendritic areas of increased potassium channel
conductance display more limited excitatory postsynaptic potential (EPSP) summation (Lujan
et al., 2003; Raab-Graham et al., 2006). The finding that each of these genes is a MEF2 target
indicates that MEF2 restricts synapse number through multiple mechanisms that together
contribute to synapse weakening and synapse elimination.
The application of genomic strategies to identify MEF2 targets at the time that synapses are
forming has also revealed new and unexpected roles for MEF2 in synapse biology.
Unexpectedly, several of the MEF2 target genes encode proteins known to localize to the
postsynaptic side of excitatory synapses and promote synaptic strengthening: Leucine-rich
glioma-inactivated 1 (Lgi1) promotes AMPAR insertion into the postsynaptic membrane by
binding to its transmembrane receptor (Fukata et al., 2006); adenylyl cyclase 8 mediates
calcium-dependent cAMP production necessary for calcium-dependent synaptic strengthening
(Wang et al., 2003); and Bdnf is known to enhance excitatory synaptic strength though a variety
of mechanisms, for instance by acting as a retrograde signal that enhances presynaptic release
(Zhang and Poo, 2002). One possible explanation for the coordinated expression of MEF2
target genes with antagonistic functions (synaptic weakening vs. strengthening) is that the
activation of MEF2 might lead to a decrease in the total number of synapses formed onto cells
through one group of target genes (e.g. homer1a, arc, kcna1, etc.) and at the same time lead
to the strengthening of a separate subset of synapses through a separate group of target genes
(e.g. adenylyl cyclase 8, bdnf, etc.). In fact, it is known that synapse elimination and synaptic
potentiation (of other synapses) occur concurrently within individual cells during synapse
development (Chen and Regehr, 2000). Further experiments will be necessary to determine
the specific synapses at which each of these different MEF2 target genes functions.
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Several of the genes identified in our screen for MEF2 target genes encode proteins that
function postsynaptically at inhibitory synapses, providing the first evidence that MEF2
regulates inhibitory synaptic function. The Cdc42 guanine nucleotide exchange factor (GEF)
Arhgef9 and the actin organizing molecule Mena both regulate the actin cytoskeleton in order
to promote the clustering of gephyrin, a scaffolding protein that is specifically found at
inhibitory synapses (Giesemann et al., 2003; Papadopoulos et al., 2007), while Bdnf is critical
for activity-dependent inhibitory synapse formation (Rutherford et al., 1997). The finding that
these genes are also included among the MEF2 target genes indicates that MEF2 may play a
positive role in promoting inhibitory synapse development in addition to its effects on
excitatory synapse development. Consistent with this idea, recent studies from our laboratory
have identified an activity-regulated transcription factor, NPAS4 (not present on the RAE230.2
microarrays used in this study), that plays a key role in the formation of inhibitory synapses
onto excitatory neurons and appears to be a direct target of MEF2 ((Lin et al., 2008); and data
not shown).
The activity-dependent activation of MEF2 within a neuron also triggers the induction of target
genes that regulate the presynaptic outputs of the neuron. For example, mUNC13, mLin7A, and
rgs2 each encode proteins that enhance synaptic vesicle release. Moreover, the neuropeptides
Somatostatin and adenylate cyclase activating polypeptide 1 (ADCYAP1, or PACAP), both
encoded by activity-regulated MEF2 target genes, are known to be secreted from presynaptic
sites and to modulate excitatory synaptic transmission (Boehm and Betz, 1997; Roberto et al.,
2001).
These data demonstrate that in response to neuronal activity MEF2 activates target genes that
regulate multiple aspects of neural circuit development and function. In addition to activating
genes that weaken excitatory synaptic inputs formed onto the MEF2-expressing neuron, MEF2
also activates additional groups of target genes that strengthen select excitatory synaptic inputs,
remodel inhibitory synaptic inputs and regulate the presynaptic outputs of the MEF2-
expressing neuron. Further experiments will be necessary to determine if these MEF2 targets
are all expressed together in the same neurons or, alternatively, if distinct subsets of these target
genes are expressed in different subsets of neurons (e.g. CA3 versus CA1 pyramidal neurons).
Nevertheless, these findings indicate that in response to an increase in neural circuit activity,
the activation of MEF2 within individual neurons in the circuit leads to the induction of an
extensive genetic program that likely plays a central role in the process of experience-
dependent synaptic development, refinement and plasticity.
MEF2 target genes that function within the nucleus
Another group of genes that is statistically over-represented among the MEF2 target genes
encode proteins that function within the nucleus to regulate transcription (p=1.75 × 10−31,
enrichment for Transcription GO category, Ingenuity; Fig. 6). Among these transcriptional
regulators are several molecules (e.g. c-fos, fosB, early growth response (egr1), egr3, nur77,
histone deacetylase 5 (hdac5) and mef2a itself) that have been documented to play a critical
role in synapse development and plasticity, although for the most part the target genes of these
transcription factors remain to be identified (Flavell et al., 2006;Fleischmann et al., 2003;Hiroi
et al., 1997;Jones et al., 2001;Li et al., 2007;Renthal et al., 2007;Shalizi et al., 2006). The
identification of these genes as MEF2 targets suggests that MEF2 induces the expression of a
set of regulatory factors that work together with MEF2 to control synaptic function. Consistent
with this idea, a number of the MEF2 targets are known to enhance MEF2 activity (IFRD1 and
Mef2a; (Micheli et al., 2005)) whereas other targets interact with MEF2 and inhibit its
transcriptional activity (the putative histone demethylase Jumonji and the histone deacetylase
HDAC5; (Kim et al., 2005;McKinsey et al., 2000)).
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MEF2 target genes in neurological disease
The importance of the MEF2 transcriptional program for neural circuit development and
function in humans is highlighted by the fact that mutations in several of the MEF2 targets in
humans give rise to neurological disorders. Mutations in the human orthologs of the MEF2
target genes lgi1, kcna1 and arhgef9 result in an imbalance between synaptic excitation and
inhibition that leads to epilepsy (Table 2 and references therein). In addition, mutations in the
human orthologs of the MEF2 target genes ube3a and solute carrier 9, member 6 (slc9a6) are
known to cause Angelman syndrome, a disorder characterized by mental retardation and
increased susceptibility to seizures. Finally, two of five mutations that were recently shown to
give rise to autism and epilepsy in families in which parents share ancestors occur within the
putative regulatory regions of protocadherin 10 and c3orf58 (Morrow et al., 2008).
Protocadherin 19, which is closely related to protocadherin 10, has also recently been linked
to epilepsy and mental retardation in several families (Dibbens et al., 2008).
The symptoms of epilepsy, Angelman syndrome and autism are typically manifested in the
first years of life during which sensory experience regulates synapse development and function.
Thus, our finding that MEF2, a transcription factor activated by sensory experience, regulates
activity-dependent synaptic development and induces the expression of a set of genes, several
of which are mutated in disorders of human cognition, suggests that a common mechanism of
these disorders may be the disruption of the activity-dependent MEF2-regulated gene
expression program. This also raises the possibility that human genetic studies combined with
the characterization of cell type-specific transcriptional programs that regulate synapse
development and maturation (like the activity-regulated MEF2 transcription program) may
provide an enhanced understanding of the molecular basis of epilepsy and autism.
CONCLUDING REMARKS
In the CNS, sensory stimulation leads to the activation of MEF2 and several other activity-
regulated transcription factors that in turn activate programs of gene expression necessary for
synapse development and remodeling (Flavell and Greenberg, 2008). By performing a series
of genome-wide analyses in hippocampal neurons at the time that synapses are developing, we
were able to effectively identify over 150 activity-regulated MEF2 target genes that are
primarily expressed in the CNS. While previous studies have utilized loss- and gain-of-function
experiments to suggest that MEF2 regulates synapse development, it has been difficult to
distinguish between the direct functions of MEF2 (mediated by its target genes) and the
homeostatic changes that occur in cells where the expression of MEF2 has been altered for
several days. The set of MEF2 targets identified in our study is enriched for genes whose protein
products are localized to synapses and these genes control multiple aspects of synaptic function.
Thus, the identification of this set of MEF2 targets provides evidence that MEF2 plays a key
role in mediating many aspects of synapse and neural circuit development.
One issue left unresolved by this study is which of the newly identified MEF2 target genes that
have not yet been shown to play a critical role in synapse development are actually involved
in this process. To address this issue, each of the MEF2-regulated genes will need to be
individually tested for their role in synapse development. The MEF2 target genes that are
known to harbor mutations and polymorphisms in the human population that lead to an
increased susceptibility to neurological disorders such as epilepsy and autism-spectrum
disorders (lgi1, arhgef9, kcna1, ube3a, slc9a6, pcdh10, c3orf58) are especially important to
test for their potential roles in synapse development. The observation that several activity-
dependent MEF2 target genes are mutated in cases of epilepsy and autism suggests that these
disorders may be caused at least in part by the disruption of important components of the
activity-regulated MEF2 genetic program that controls neural circuit development.
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Our approach to MEF2 target gene identification also revealed a novel feature of the activity-
dependent genetic program. Neuronal activity promotes the use of alternative sites of polyA
addition at many of the MEF2 target genes, which results in the activity-dependent production
of truncated mRNAs and in some cases truncated proteins (Fig. 5E). In cases where activity-
dependent polyA site switching leads to truncated proteins, these proteins are frequently
predicted to act dominantly to alter the function of pre-existing full-length proteins. In other
cases where activity-dependent polyA site switching leads to shortened mRNAs that contain
full-length open reading frames but shortened 3′ UTRs, this switch will not alter protein
function but instead will likely alter when and where the mRNAs are translated. We
hypothesize that stimulus-dependent changes in polyadenylation site usage may thus provide
a mechanism to acutely alter gene function in response to changes in a cell’s extracellular
environment.
It is likely that the genomic approaches that we have used to study MEF2 function in neurons
can be generally applied to elucidate the gene expression programs that control different aspects
of neural development. In addition, the further characterization of stimulus-regulated
transcriptional programs in neurons and other cell types should provide new insights into the
importance of polyA site switching in stimulus-dependent transcriptional control and should
more generally reveal the molecular mechanisms by which extracellular factors induce
complex cellular responses that allow multi-cellular organisms to adapt to changes in their
environment.
EXPERIMENTAL PROCEDURES
Cell Culture
Hippocampal neurons from E18 Long-Evans rats were isolated as previously described (Xia
et al., 1996). Detailed information about cell culture conditions, lentiviral vectors and
pharmacological agents is available in Supplemental Data.
Plasmids
MEF2A and MEF2D shRNA constructs were previously described (Flavell et al., 2006).
Descriptions of the plasmids encoding MEF2-VP16-ER and the bdnf luciferase reporter
plasmids are available in the Supplemental Data.
Exposure of rats to novel environment
Novel environment experiments were conducted using standard procedures. Details are
available in Supplemental Data.
Mouse visual cortex stimulation
Detailed protocols for mouse visual stimulation and visual cortex isolation are available in
Supplemental Data.
mRNA profiling microarray analyses
For expression profiling of cultured neurons, three biological replicates of each experiment
were performed. For the novel environment experiment, RNA was collected from six animals
for each experimental condition. Arrays from all experimental conditions (and all replicates)
of a given experiment were normalized to one another and all subsequent analyses were
conducted using GeneSpring GX software (Agilent, Santa Clara, CA). Additional details about
RNA isolation, sample preparation and array analysis methods are available in Supplemental
Data.
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Identification of multiple probe sets mapping to individual genes
To identify cases where multiple probe sets mapping to the same gene showed different
expression profiles, we used standard procedures that are described in detail in Supplemental
Data.
Statistical Analyses and Comparisons
Statistical methods used to investigate MEF2 target gene expression in different tissues
(through GNF Atlas 2 data), as well as details about Ingenuity Pathway analyses, are available
in Supplemental Data.
Reverse Transcription-quantitative PCR (RT-qPCR)
All RT-qPCR experiments were performed essentially as previously described (Flavell et al.,
2006). Details are available in Supplemental Data.
Luciferase Assays
All luciferase assays were performed essentially as previously described (Flavell et al.,
2006). Details are available in Supplemental Data.
Antibodies
The antibodies used in all experiments are described in Supplemental Data.
Chromatin-immunoprecipitation (ChIP)
Typically 20–40 million hippocampal neurons were used for a single ChIP experiment. A
detailed description of the ChIP procedure is available in Supplemental Data.
Quantitative-PCR (qPCR) using ChIP samples
ChIP analysis of all individual genomic regions was conducted using qPCR and is described
in Supplemental Data.
ChIP-chip
The arrays used for ChIP-chip were manufactured by Nimblegen Systems, Inc (Madison, WI).
We performed two biological replicates of each ChIP-chip experiment, which included three
different stimulation conditions (unstimulated, 20 and 140 min after KCl depolarization, which
was conducted as described above). Furthermore, each ChIP experiment was paired with a
negative control ChIP reaction that was performed with a negative control antibody. For
MEF2D ChIP, the negative control antibody was a MEF2D antibody that was pre-blocked with
antigen peptide. For RNA Polymerase II ChIP, mouse IgG mix (Santa Cruz Biotechnology,
Inc) was used as a negative control. Details about microarrays and ChIP-chip library
preparation are available in Supplemental Data.
ChIP-chip data analysis
Signal intensity data was extracted from the scanned images of each array using NimbleScan,
NimbleGen’s data extraction software. Subsequently, scaled log2-ratio values from each probe
were obtained (log2[ChIP signal intensity/input signal intensity]). The log2-ratio was computed
and scaled to center these values around zero. Scaling was performed by subtracting the bi-
weight mean for the log2-ratio values for all features on the array from each log2-ratio value.
We then identified regions of MEF2D and RNA polymerase II occupancy using a custom-
written ChIP-chip data analysis program that was implemented using the R language and is
composed of three parts that are described in Supplemental Data.
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Bioinformatic analyses
Methods used to investigate evolutionary conservation and sequence motifs within the rodent
genome are described in Supplemental Data.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. mRNA profiling analysis reveals activity-regulated MEF2 target genes
(A) 643 probe sets whose expression is upregulated in E18+10 days in vitro (DIV) hippocampal
neurons upon KCl-mediated membrane depolarization were identified by microarray analysis.
Probe sets with similar expression profiles were clustered together using a Pearson correlation-
based method and the expression levels of each of these probe sets (each line represents a single
probe set) are displayed as a log2ratio of their expression values after one or six hours after
KCl depolarization divided by their expression value in unstimulated (0 hour) cells. (B) 1365
probe sets whose expression is downregulated in E18+10 DIV hippocampal neurons in the
presence of MEF2 RNAi were identified by microarray analysis. These probe sets were
clustered as in (A) and expression levels are displayed as a log2ratio of their expression values
in the presence of MEF2 RNAi divided by their expression values under control conditions for
each of the three time points examined. (C) 251 probe sets whose expression is upregulated by
4OHT application to MEF2-VP16-ER-expressing hippocampal neurons at E18+10 DIV were
identified by microarray analysis. Probe sets were clustered as in (A) and their levels of
expression are displayed as the log2ratio of the expression value one or 2.5 hours after 4OHT
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application divided by the expression value prior to 4OHT application. (D) Venn Diagram
showing the overlap of the probe sets identified in the three gene sets shown in (A–C). The
levels of overlap between each of these three gene sets are statistically significant (p<0.0001
for all three comparisons, Fisher Exact Test). (E) 304 probe sets whose expression is
upregulated in forebrains of rats exposed to a novel environment for three hours were identified
by microarray analysis. These probe sets were clustered as in (A) and their levels of expression
are displayed as the log2ratio of their expression values in each individual animal divided by
the mean expression value of all control animals.
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Figure 2. MEF2D ChIP-chip identifies MEF2 binding sites surrounding the candidate target genes
(A) Method for the identification of MEF2 binding sites by ChIP-chip. Sonicated DNA
fragments enriched by MEF2D immunoprecipitation (yellow) will center on the site of MEF2D
binding (red). The intensity of the signals from several consecutive probe sets on the tiling
microarray that correspond to this genomic region will be identified as a peak of MEF2D
binding. (B) Example of a genomic region of MEF2D occupancy identified at the lgi1 gene
locus. Raw data from one representative experiment are shown in the two upper panels. The
genomic region identified by our peak calling algorithm is shown in red, and the annotated
RefSeq lgi1 mRNA (exons shown as blue boxes, introns shown as blue lines with arrows that
indicate direction of transcription) as well as level of evolutionary conservation within this
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genomic region are shown below. (C) An example of genomic regions of RNA Polymerase II
occupancy is shown as in (B). In addition, rat expressed sequence tags (ESTs) are shown to
indicate where un-annotated mRNAs are likely to exist in this region of the rat genome. (D)
Distribution of the regions of RNA Polymerase II occupancy relative to annotated RefSeq
mRNAs. For this graph, the genomic loci of all genes were scaled to 40 kilobases (kb) and
regions of RNA polymerase II occupancy are plotted according to their positions at or near the
genes. (E) Histogram of the PhastCons evolutionary conservation scores within the entire
custom tiling microarray (blue) or within the MEF2D-bound regions of the custom tiling
microarray (red). These distributions are bimodal, as the majority of the nucleotides in the rat
genome are either non-conserved (close to zero) or highly conserved (close to one). Asterisks
are shown to indicate that these two distributions are significantly different (p<0.001, Chi-
Square test). (F) Logo of the MEF2 response element (MRE) that was identified as significantly
enriched within the MEF2-bound genomic regions. (G) Mean PhastCons scores of genomic
regions surrounding each occurrence of the MRE in (F) are shown. The nucleotides
corresponding to the MRE are between the red lines, whereas the 400 nucleotides adjacent to
each MRE surround the red lines. Mean PhastCons scores are shown for regions surrounding
MREs within the MEF2D-bound regions of the tiling microarry (black) or within random
regions of the rat genome (cyan). The mean PhastCons scores of all the nucleotides in the rat
genome are also displayed (dotted black line). The PhastCons scores of the MREs within the
MEF2D-bound regions are significantly higher than those within random regions of the rat
genome (p<0.01, Chi-Square test).
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Figure 3. Location of the genomic regions of MEF2D occupancy at MEF2-regulated genes
(A) Distribution of the regions of MEF2D occupancy along the MEF2-regulated genes, plotted
as in Fig. 2D. (B) Example of a region of MEF2D occupancy that was identified within the
proximal promoter of a MEF2-regulated gene (lgi1). The identified regions of MEF2D and
RNA Polymerase II occupancy are shown in red, along with the annotated lgi1 gene and the
level of evolutionary conservation within this genomic region. (C) Example of a region of
MEF2D occupancy that was detected at a site of RNA Polymerase II occupancy upstream of
the 5′ end of a RefSeq annotated mRNA (kcna4). (D) Example of a region of MEF2D
occupancy detected far upstream (~6.5 kb) of the annotated transcriptional start site (TSS) of
a MEF2-regulated gene (bndf). This genomic region was cloned into the luciferase reporter
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constructs that are depicted below (MEF2-bound region is depicted as a red box). (E)
Normalized luciferase activity in lysates from E18+6 DIV hippocampal neurons that were
transfected with the indicated luciferase reporter constructs and either treated with elevated
levels of extracellular KCl (blue) or left untreated (white). Data are shown as means ± standard
error of the mean (SEM). P<0.01, two-factor analysis of variance (ANOVA); asterisks indicate
statistical significance in pairwise comparison: P<0.01, Bonferroni-Dunn post-hoc test.
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Figure 4. Neuronal activity-dependent alternative polyadenylation site usage
(A) Upper: example of a gene (kif5c) that was identified through microarray analyses to display
an activity-dependent change in polyA site usage. Rat ESTs that were sequenced with polyA
tails intact are shown at the 3′ ends of the two kif5c mRNAs that were independently measured
on the RAE230.2 micoarray. Lower: RT-qPCR confirmation of these microarray results for
four genes. Expression of each gene was measured through two distinct primer sets that
correspond to different 3′ ends of mRNAs produced by the gene that were independently
represented on the microarray. Expression of these genes was normalized to that of beta-3-
tubulin and data are shown as means ± SEM. (B) RT-qPCR analysis conducted as in (A). Gene
expression in these experiments was measured in neurons in primary visual cortex in both
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control animals and animals that had been acutely exposed to light stimulation. Expression of
these genes was normalized to that of beta-3-tubulin and data are shown as means ± SEM.
Asterisk indicates significant increase in mRNA expression (p<0.05, t-test) in animals exposed
to visual stimulation versus dark-reared control animals. None of the full-length mRNAs
showed a significant change by these same criteria. (C) Changes in gene expression in response
to 6 hours of KCl treatment for truncated and full-length mRNAs produced by individual genes.
All genes that were identified through microarray analysis as having disparate expression data
between two or more probe sets mapping to the same gene are displayed. There is a strong bias
for the activity-regulated probe set to correspond to the truncated mRNA (blue) rather than the
full-length mRNA (red). Inset: number of genes belonging to these two categories. (D)
Distribution of polyA signal hexamers surrounding the polyA regions. The exact locations of
19 polyA sites that in depth analyses indicated were high confidence sites of activity-dependent
polyadenylation were used in this analysis. The polyA signal hexamers that were acceptable
in our analysis were those identified by Tian et al. (2005). (E) Nucleotide density at the genomic
regions surrounding the polyA sites that display activity-dependent use. Same polyA sites that
were analyzed in (D) were used here. (F) Above: cartoon depicting a generic gene that has two
distinct mRNA isoforms with different 3′ ends. For four such genes, RT-PCR was performed
with two primer sets. For each gene, the primer sets shared the same forward primer in a 5′
exon within the gene, but had different isoform-specific reverse primers, as is shown. Using a
cDNA template prepared from hippocampal neuron RNA, all RT-PCR reactions yielded
products of the correct predicted length (below). Note that two distinct splice forms
(corresponding to two bands) of the short jip3 transcript were amplified; also note that the 3′
UTR of the truncated camk2d isoform is especially long, so that this mRNA is larger than the
full-length isoform even though it lacks several 3′ protein-coding exons.
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Figure 5. Features of polyA regions that display activity-dependent use
(A) Data from two independent ChIP experiments conducted with an antibody against the
elongating form of RNA polymerase II are shown as levels of RNA polymerase II enrichment
at the indicated locations in the mouse genome, normalized to a negative control intergenic
region that does not display RNA polymerase II occupancy. Note that analyses of microarray
data (Fig. 1) indicate activity-dependent polyA site switching at homer1, while polyA site
switching at sh3 multiple domains 4 (sh3md4), AU RNA binding protein/enoyl-Coenzyme A
Hydratase (auh) and tubulin, gamma complex associated protein 4 (tubgcp4) is indicated by
additional expression analyses (data not shown). Data are shown as means ± SEM; asterisk
indicates statistically significant increase in RNA polymerase II occupancy for a given genomic
region (p<0.01, Two-Factor ANOVA). (B) Logo of a novel motif that was identified as highly
enriched in the regions surrounding the truncated polyA regions. (C) RT-qPCR analysis of
mRNA expression of the indicated truncated and full-length mRNAs. The fold induction of
mRNA expression was analyzed in response to six hours of membrane depolarization in the
absence or presence of the indicated inhibitors. Data from one representative experiment are
shown as means ± SEM. (D) Sets of genes identified through microarray analysis as displaying
polyA site switching in response to different extracellular stimuli. Note that there is almost no
overlap between these different sets of genes. (E) Model for activity-regulated polyadenylation
site switching. At several MEF2 target genes, and other genes that display activity-dependent
transcription, neuronal activity promotes both increased levels of transcription and increased
usage of internal polyadenylation sites, which leads to a robust increase in the abundance of
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short mRNAs that differ from the full-length mRNAs produced in the absence of neuronal
activity. The calcium-dependent activation of MEF2 is mediated in large part through the
calcineurin (CaN)-dependent dephosphorylation of MEF2 proteins, while calcium-dependent
polyadenylation site switching is mediated through signal transduction pathways that remain
unknown. Note that although these processes are coupled at individual genes (like the gene
depicted in the model), the signaling pathways that lead to activity-dependent transcription and
polyA site switching might be completely independent.
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Figure 6. MEF2 target genes that function at the synapse and in the nucleus
The list of newly identified MEF2 target genes was enriched for genes that encode
transcriptional regulators and for genes that encode proteins that function at the synapse.
Several examples of these types of genes are shown. See main text for additional details.
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Table 1
Genes that display a neuronal activity-dependent switch in polyadenylation site usage
These genes are divided into two groups. The 18 MEF2- and activity-regulated genes listed were included among the
182 MEF2 target genes that we identified, while the 41 activity-regulated genes (not MEF2-regulated) that are listed
were included among the 643 activity-regulated genes identified in our study, but did not display evidence of MEF2-
dependent regulation.
MEF2- and activity-regulated genes
Common Name Description
JSAP1 JNK/SAPK-associated protein 1
Odz2 odd Oz/ten-m homolog 2 (Drosophila)
Arhgef9 Cdc42 guanine nucleotide exchange factor (GEF) 9
Csnk1e Casein kinase 1, epsilon
Vesl-1; HOMER1F homer homolog 1 (Drosophila)
Pcdh9_predicted Protocadherin 9 (predicted)
Omp25 synaptojanin 2 binding protein
Pkib protein kinase (cAMP dependent, catalytic) inhibitor beta
LOC299907 similar to Ext1
LOC498145 similar to RIKEN cDNA 2810453I06
Septin 11 Septin 6 (predicted)
Rybp_predicted RING1 and YY1 binding protein (predicted)
Rinzf zinc finger and BTB domain containing 10
RGD1566117_predicted similar to hypothetical protein FLJ23033
RGD1311381_predicted similar to hypothetical protein FLJ20037 (predicted)
Klf6 Core promoter element binding protein
RGD1308432_predicted similar to cDNA sequence BC020002 (predicted)
Tcf4 Transcription factor 4
Activity-regulated genes (not MEF2-regulated)
Common Name Description
Usp9x_predicted similar to ubiquitin specific protease 9, X-linked (fat facets-like, Drosophila)
Syncrip synaptotagmin binding, cytoplasmic RNA interacting protein (predicted)
Dab1 disabled homolog 1 (Drosophila)
Arih1 ariadne ubiquitin-conjugating enzyme E2 binding protein homolog 1 (Drosophila) (predicted)
HSPG syndecan 2
Camk2d Calcium/calmodulin-dependent protein kinase II, delta
Rnf153 ring finger protein 153 (predicted)
Rab21 RAB21, member RAS oncogene family
Impad1 inositol monophosphatase domain containing 1
Kif5c_predicted Kinesin family member 5C (predicted)
Mbd1 Methyl-CpG binding domain protein 1 (predicted)
LOC363153 Similar to protein phosphatase 1, regulatory(inhibitory) subunit 1C; thymocyte ARPP;
RGD1562438_predicted similar to amyloid beta (A4) precursor protein- binding, family B, member 2
Gpr177 CG6210-like
Ppp1r2 protein phosphatase 1, regulatory (inhibitor) subunit 2
Zfp68_predicted zinc finger protein 68 (predicted)
Idb4 inhibitor of DNA binding 4
Pabpn1 poly(A) binding protein, nuclear 1
Usp19 ubiquitin specific protease 19
Ssr1 signal sequence receptor, alpha (predicted)
Txnl; MGC114276 thioredoxin-like (32kD)
Pofut2_predicted protein O-fucosyltransferase 2 (predicted)
Spred1 sprouty protein with EVH-1 domain 1, related sequence (predicted)
Csrp2bp_predicted cysteine and glycine-rich protein 2 binding protein (predicted)
Vcip135 valosin-containing protein (p97)/p47 complex- interacting protein 135
Cachd1_predicted cache domain containing 1 (predicted)
Josd3 Josephin domain containing 3
Pafah1b1 platelet-activating factor acetylhydrolase, isoform Ib, alpha subunit 45kDa
Ahctf1_predicted AT hook containing transcription factor 1 (predicted)
Degs degenerative spermatocyte homolog (Drosophila)
Cggbp1_predicted CGG triplet repeat binding protein 1 (predicted)
AIP1; Alix programmed cell death 6 interacting protein
Rptpk Protein tyrosine phosphatase, receptor type, K, extracellular region
Ppp2r2a Protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), alpha isoform
Rnpc2 RNA-binding region (RNP1, RRM) containing 2(predicted)
similar to DIP13 alpha (predicted)
RGD1307879_predicted similar to hypothetical protein D10Ertd438e (predicted)
RGD1309054_predicted similar to FKSG26 protein (predicted)
RGD1559923_predicted similar to chromosome 14 open reading frame 35
proteasome (prosome, macropain) activator subunit 4
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MEF2- and activity-regulated genes
Common Name Description
RGD1310651_predicted Similar to hypothetical protein MGC20460(predicted)
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Table 2
MEF2 target genes related to epilepsy and autism-spectrum disorders in humans.
Disease Gene Name Gene Symbol Reference (Pubmed ID)
Epilepsy leucine-rich, glioma inactivated 1 lgi1 11810107
Epilepsy potassium voltage-gated channel, shaker-related subfamily,
member 1
kcna1 10414318
Epilepsy Cdc42 guanine nucleotide exchange factor (GEF) 9 arhgef9 15215304
Angelman syndrome ubiquitin protein ligase E3A ube3a 8988171
Angelman syndrome solute carrier family 9 (sodium/hydrogen exchanger), member 6 slc9a6 18342287
Autism/Epilepsy protocadherin 10 Pcdh10 18621663
Autism/Epilepsy chromosome 3, open reading frame 58 c3orf58 18621663
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